- Home
- OPY vs ABSI Comparison
OPY vs ABSI Comparison
Compare OPY & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPY | ABSI |
|---|---|---|
| Founded | 1881 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPY | ABSI |
|---|---|---|
| Price | $90.95 | $10.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $14.82 |
| AVG Volume (30 Days) | 85.2K | ★ 3.9M |
| Earning Date | 10-30-2026 | 11-12-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ 104.71 | 10.64 |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $1,638,071,000.00 | $4,534,000.00 |
| Revenue This Year | N/A | $39.03 |
| Revenue Next Year | N/A | $310.91 |
| P/E Ratio | $84.16 | ★ N/A |
| Revenue Growth | ★ 14.35 | N/A |
| 52 Week Low | $63.81 | $2.24 |
| 52 Week High | $125.88 | $12.54 |
Technical Indicators
Market Signals| Indicator | OPY | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 33.18 | 50.62 |
| Support Level | $90.00 | $8.15 |
| Resistance Level | $94.08 | $10.03 |
| Average True Range (ATR) | 4.72 | 0.98 |
| MACD | -1.45 | 0.08 |
| Stochastic Oscillator | 27.66 | 42.49 |
Price Performance
Historical ComparisonAbout OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.